Back

No Feature content logo

Clinical Pharmacology Considerations for Novel Therapeutic Modalities - Webinar

Posted by William

126 days ago

This webinar will discuss the clinical pharmacology considerations for the development of novel therapeutic modalities. Our FDA subject matter experts will also address the unique considerations for oligonucleotide therapeutics and antibody-drug conjugates with respect to topics such as dose selection, exposure/response analysis, organ impairment, drug interactions, QTc assessment, and immunogenicity. 

Register here ➡️ Clinical Pharmacology Considerations for Novel Therapeutic Modalities - 12/04/2024 | FDA


Show More
Get Your Copy
Please fill out the required information.

First Name is required.
Last Name is required.
Business Email is required.
Job Title is required.
Company Name is required.